Cosmos Health Projects Over $3.2M in Annual Revenue from New Fort18 Supplement Launch
COSM is trading near its 52-week low of $0.281 (14% above the low).
Summary
Cosmos Health Inc. projects over $3.2 million in incremental annual U.S. revenue from its new Fort18™ sexual health supplement within the next 12-18 months, with a commercial launch anticipated in June 2026. This announcement follows a similar projection of $2.5 million in incremental annual revenue from its Cur18 supplement just 11 days prior, establishing a pattern of new product revenue guidance. For a company with a market capitalization of approximately $16 million, this $3.2 million projection represents a material potential revenue stream, equating to roughly 20% of its current valuation. This news is particularly significant given the company's recent 10-K filing which included a going concern warning and highlighted increased net losses and cash burn. Traders will closely monitor the successful execution of the commercialization strategy for Fort18™ and other new products as the company seeks to address its financial challenges.
At the time of this announcement, COSM was trading at $0.32 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $16.3M. The 52-week trading range was $0.28 to $1.32. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Access Newswire.